During endotracheal intubation, a catheter called an endotracheal tube is placed into the trachea and a gaseous mixture is pumped through it to induce anesthesia. The orotracheal tube and the nasotracheal tube are both examples of endotracheal tubes used in the administration of anesthesia. The nasotracheal tube is inserted into the trachea through the nasal passages, while the orotracheal tube is inserted into the trachea through the oral cavity.
Global anesthesia endotracheal tube market is estimated to be valued at US$ 178.7 million in 2022 and is expected to exhibit a CAGR of 6.2% during the forecast period (2022-2030).
Click Here to Request a sample copy @ https://www.coherentmarketinsights.com/insight/request-sample/2025
The demand for endotracheal tubes used in anesthetic procedures is anticipated to rise as the frequency of long-term surgical procedures rises.
Endotracheal tubes are used to administer anesthetic during a variety of surgical operations for the management and therapy of conditions as diverse as gastrointestinal disease, cardiovascular disease, spinal abnormality, urological disorder, orthopedic deformity, and brain tumors. As a result, the anesthesia endotracheal tubes market is expected to expand over the predicted time period as the number of surgical procedures increases globally. According to the National Center for Biotechnology Information, there will be 310 million major procedures conducted worldwide in 2021; of those, 40–50 million will be performed in the United States and 20 million in Europe. It is estimated that 8 million people worldwide die annually as a direct result of major surgery, and that another 2–4 million people have some sort of postoperative problem. The insertion of a tube into the windpipe (trachea). Physicians, nurses, and other medical professionals who work at hospitals, clinics, and other care facilities, including but not limited to emergency rooms, operating rooms, perioperative areas, and (all places with intubated patients).
Anesthesia endotracheal tubes are anticipated to benefit from an older population, as more people in that demographic suffer from respiratory conditions such as asthma, pulmonary illness, and chronic obstructive pulmonary disease.
Anesthesia endotracheal tubes are anticipated to benefit from an older population, as more people in that demographic suffer from respiratory conditions such as asthma, pulmonary illness, and chronic obstructive pulmonary disease.According to U.S. statistics on the ageing of the world’s population, the number of individuals aged 60 and above is expected to increase by 56% between 2017 and 2030, from 901 Mn to 1.4 Bn, and to nearly double again by 2050, from 1.52 Bn to nearly 2.1 Bn.
Furthermore, in 2018, chronic bronchitis affected 9.0 Mn adults, or 3.6% of the population aged 18 and up, as reported by the American Lung Association. Fifteen papers reporting prevalence of chronic obstructive pulmonary disease according to gold standard diagnostic criteria and post-bronchodilation spirometry. Around 10% of people aged 40 and up have chronic obstructive pulmonary disease (COPD), though this varies widely between nations and increases with age. More than 120,000 Americans fall victim to it every year, making it the fourth greatest cause of death in the country and the third largest cause worldwide.
Global Anesthesia Endotracheal Tube Market– Impact of Coronavirus (COVID-19) Pandemic
There has been an outbreak of the COVID-19 virus since December 2019, and on January 30, 2020, the World Health Organization has declared a public health emergency.
There are three primary ways in which COVID-19 can influence the economy: through effects on drug supply and demand, disruptions in distribution networks, and monetary effects on businesses and the financial sector. China, India, Saudi Arabia, the United Arab Emirates, Egypt, and other countries are experiencing difficulties with drug shipments as a result of statewide lockdowns.
Despite this, the global anesthesia endotracheal tube market benefited from the COVID-19 pandemic as a result of rising demand from patients with pulmonary diseases. An international observational study of 1128 patients with perioperative COVID-19 who underwent a variety of surgical procedures reported high rates of postoperative pulmonary complications and mortality in October 2021. This was published by the American Society of Anesthesiologists (ASA) and the Anesthesia Patient Safety Foundation (APSF). 51% of patients developed pulmonary problems, and of those, 38% died within 30 days. Patients older than 70 years old, men specifically, and those who underwent emergency surgery had a higher risk of death (26 vs. 19%) than those who underwent elective surgery. Preoperative diagnosis of COVID-19 was made in 22 of 280 patients undergoing elective surgery; two of these individuals subsequently passed away. General guidelines on timing of elective surgery after COVID-19 infection were issued by the Anesthesia Patient Safety Foundation (APSF) and the American Society of Anesthesiologists (ASA) in a joint statement in 2022. These guidelines took into account the degree of illness at the time of infection, ongoing symptoms, comorbidities, and complexity of surgery. Due to the potential for aerosol formation during mask breathing, some guidelines produced during the COVID-19 pandemic suggested that rapid sequence induction and intubation (RSII) be used frequently for patients with COVID-19.
Key Players
The main companies participating in the market of anesthesia endotracheal tube worldwide are Medtronic Plc, General Electric Company, C. R. Bard, Inc., ConvaTec Group plc, Smith Medical, Inc., KindWell Medical Equipment Co.,Ltd, Royax, Fuji Systems Corp., Teleflex Incorporated, Neurovision Medical Products, and Intersurgical GmbH.
Buy-Now this Premium Report @ https://www.coherentmarketinsights.com/insight/buy-now/2025
Global Anesthesia Endotracheal Tube Market: Key Developments
U.S. Food and Drug Administration Approval for First X-ray AI to aid in assessing endotracheal tube insertion were granted to GE Healthcare, a subsidiary of the New York-based multinational conglomerate General Electric, in the month of November 2021. GE Healthcare recently shared that its AI system for evaluating Endotracheal Tube (ETT) insertions had been granted 510(k) clearance by the FDA. GE Healthcare’s Critical Care Suite 2.0 incorporates five AI solutions, including the one in question, to automate measurements, prioritize cases, and provide quality control in a way that has never been done before in the x-ray sector.
Global Anesthesia Endotracheal Tube Market: Restraint
Lack of sufficient health care facilities, especially in poor countries and in remote locations, is a key issue that restrains growth of the global anesthetic endotracheal tube market. Market expansion for anesthesia endotracheal tubes is likely to be limited by factors such as the scarcity of anesthetists and certified nurses per population and the absence of product recalls. Endotracheal intubation, for example, is the insertion of a tube into the trachea through the mouth or nose for the purpose of airway control, as stated by the National Center for Biotechnology Information in November 2017. One of the most crucial abilities of a doctor is airway management. In an emergency situation, failure to supply adequate airflow may result in the patient’s death or serious complications. Without premedication, intubating trauma patients with a high Glasgow Coma Scale is dangerous because it can cause the patient to vomit, which can lead to an esophageal intubation and an increased risk of aspiration. In children and babies, special care is needed because the reasons for endotracheal intubation might vary widely.
Reason to Buy this Report:
■ Analysis of the impact of technological advancements on the market and the emerging trends shaping the industry in the coming years.
■ Examination of the regulatory and policy changes affecting the market and the implications of these changes for market participants.
■ Overview of the competitive landscape in the Anesthesia Endotracheal Tube market, including profiles of the key players, their market share, and strategies for growth.
■ Identification of the major challenges facing the market, such as supply chain disruptions, environmental concerns, and changing consumer preferences, and analysis of how these challenges will affect market growth.
■ Evaluation of the potential of new products and applications in the market, and analysis of the investment opportunities for market participants.
Ask Here for Customization Report @ https://www.coherentmarketinsights.com/insight/request-customization/2025
Table of Contents with Major Points:
Executive Summary
- Introduction
- Key Findings
- Recommendations
- Definitions and Assumptions
Executive Summary
Market Overview
- Definition of Anesthesia Endotracheal Tube Market
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Trends and Developments
Key Insights
- Key Emerging Trends
- Key Developments Mergers and Acquisition
- New Product Launches and Collaboration
- Partnership and Joint Venture
- Latest Technological Advancements
- Insights on Regulatory Scenario
- Porters Five Forces Analysis
Qualitative Insights Impact of COVID-19 on Global Anesthesia Endotracheal Tube Market
- Supply Chain Challenges
- Steps taken by Government/Companies to overcome this impact
- Potential opportunities due to COVID-19 outbreak
Conclusion
Appendix
- Data Sources
- Abbreviations
- Disclaimer
TOC Continued…!
Explore More Report:
Middle east and asia injectable drugs market
North america medical carts market
Special purpose needles market
Medical micro surgical drills market
Veterinary orthopedic implants market
Degenerative disc disease treatment market
North america scar treatment market
𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com